Omnicell (NASDAQ:OMCL – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.650-1.720 for the period, compared to the consensus earnings per share estimate of 1.370. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Omnicell also updated its Q4 guidance to $0.55-$0.62 EPS.
Omnicell Trading Up 0.1 %
NASDAQ OMCL traded up $0.03 during trading on Friday, hitting $48.67. 683,792 shares of the company’s stock traded hands, compared to its average volume of 528,146. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.05 and a quick ratio of 2.22. Omnicell has a 12-month low of $25.12 and a 12-month high of $55.74. The business has a 50 day moving average of $43.26 and a 200-day moving average of $35.17.
Omnicell (NASDAQ:OMCL – Get Free Report) last posted its earnings results on Thursday, August 1st. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.37. The firm had revenue of $276.80 million for the quarter, compared to the consensus estimate of $254.41 million. Omnicell had a positive return on equity of 2.55% and a negative net margin of 1.66%. The business’s quarterly revenue was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.29 earnings per share. As a group, equities analysts forecast that Omnicell will post 0.64 earnings per share for the current year.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on OMCL
About Omnicell
Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
See Also
- Five stocks we like better than Omnicell
- Best Stocks Under $5.00
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Golden Cross Stocks: Pattern, Examples and Charts
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Stock Sentiment Analysis: How it Works
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.